E. Ohman J:or Asset Management’s Boston Scientific BSX Stock Holding History

E. Ohman J:or Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.19M	Sell	51,275 -541,890	-91%	-$29.4M	0.05%	184
2026 Q1	$37.2M	Buy	593,165 +28,694	+5%	+$2.3M	0.98%	24
2025 Q4	$53.8M	Buy	564,471 +167,052	+42%	+$16.4M	1.25%	14
2025 Q3	$38.8M	Sell	397,419 -16,897	-4%	-$1.75M	0.91%	25
2025 Q2	$44.5M	Buy	414,316 +42,616	+11%	+$4.31M	1.11%	18
2025 Q1	$37.5M	Sell	371,700 -210,245	-36%	-$21.2M	1%	26
2024 Q4	$52M	Sell	581,945 -78,440	-12%	-$6.91M	1.21%	17
2024 Q3	$55.3M	Sell	660,385 -34,459	-5%	-$2.72M	1.37%	17
2024 Q2	$53.5M	Sell	694,844 -7,426	-1%	-$544K	1.33%	17
2024 Q1	$48.1M	Buy	702,270 +27,055	+4%	+$1.74M	1.23%	21
2023 Q4	$39M	Sell	675,215 -47,533	-7%	-$2.54M	1.43%	18
2023 Q3	$38.2M	Buy	722,748 +593,000	+457%	+$31.1M	1.44%	14
2023 Q2	$7.02M	Sell	129,748 -75,500	-37%	-$3.94M	0.25%	58
2023 Q1	$10.3M	Sell	205,248 -4,000	-2%	-$189K	0.4%	49
2022 Q4	$9.68M	Sell	209,248 -2,800	-1%	-$121K	0.42%	50
2022 Q3	$8.21M	Sell	212,048 -59,352	-22%	-$2.38M	0.37%	52
2022 Q2	$10.1M	Buy	271,400 +46,400	+21%	+$1.89M	0.44%	46
2022 Q1	$9.97M	Buy	+225,000	New	+$9.75M	0.33%	55
2021 Q4	–	Sell	-61,000	Closed	-$2.65M	–	443
2021 Q3	$2.65M	Hold	61,000	–	–	0.08%	146
2021 Q2	$2.61M	Buy	+61,000	New	+$2.57M	0.08%	149
2021 Q1	–	Sell	-26,100	Closed	-$938K	–	450
2020 Q4	$938K	Sell	26,100 -5,900	-18%	-$213K	0.04%	233
2020 Q3	$1.22M	Hold	32,000	–	–	0.06%	152
2020 Q2	$1.12M	Buy	+32,000	New	+$1.15M	0.06%	148
2019 Q2	–	Sell	-54,300	Closed	-$2.08M	–	376
2019 Q1	$2.08M	Sell	54,300 -1,000	-2%	-$38.2K	0.14%	90
2018 Q4	$1.95M	Sell	55,300 -9,900	-15%	-$359K	0.14%	93
2018 Q3	$2.51M	Buy	65,200 +6,700	+11%	+$234K	0.16%	97
2018 Q2	$1.91M	Buy	58,500 +17,500	+43%	+$528K	0.14%	110
2018 Q1	$1.12M	Buy	41,000 +2,400	+6%	+$65.2K	0.09%	142
2017 Q4	$957K	Buy	38,600 +100	+0.3%	+$2.76K	0.08%	163
2017 Q3	$1.12M	Buy	38,500 +1,200	+3%	+$33.1K	0.1%	136
2017 Q2	$1.03M	Hold	37,300	–	–	0.1%	140
2017 Q1	$928K	Buy	37,300 +7,000	+23%	+$170K	0.11%	151
2016 Q4	$655K	Hold	30,300	–	–	0.09%	171
2016 Q3	$721K	Buy	30,300 +4,600	+18%	+$110K	0.11%	147
2016 Q2	$601K	Hold	25,700	–	–	0.1%	156
2016 Q1	$483K	Hold	25,700	–	–	0.09%	168
2015 Q4	$474K	Hold	25,700	–	–	0.08%	178
2015 Q3	$422K	Hold	25,700	–	–	0.11%	176
2015 Q2	$455K	Sell	25,700 -7,000	-21%	-$125K	0.11%	186
2015 Q1	$580K	Hold	32,700	–	–	0.13%	159
2014 Q4	$437K	Hold	32,700	–	–	0.1%	201
2014 Q3	$386K	Hold	32,700	–	–	0.09%	216
2014 Q2	$418K	Hold	32,700	–	–	0.1%	199
2014 Q1	$442K	Hold	32,700	–	–	0.11%	194
2013 Q4	$393K	Hold	32,700	–	–	0.09%	222
2013 Q3	$384K	Hold	32,700	–	–	0.1%	225
2013 Q2	$303K	Buy	+32,700	New	+$277K	0.08%	258

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

E. Ohman J:or Asset Management's BSX Position: Q2 2026 in Review

E. Ohman J:or Asset Management reduced its Boston Scientific (BSX) stake by 91% in Q2 2026, selling an estimated $29.4M and leaving 51,275 shares worth $2.19M. The position accounts for 0.05% of the portfolio, ranked #184.

E. Ohman J:or Asset Management first reported a position in BSX in Q2 2013 and has held it in 47 quarters since. The position peaked at $55.3M in Q3 2024. 844 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

E. Ohman J:or Asset Management held 51,275 shares of Boston Scientific worth $2.19M as of Q2 2026.
E. Ohman J:or Asset Management sold 541,890 Boston Scientific shares in Q2 2026, an estimated $29.4M.
Boston Scientific made up 0.05% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #184 holding.
E. Ohman J:or Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 47 quarters since.
E. Ohman J:or Asset Management's Boston Scientific position peaked at $55.3M in Q3 2024.
844 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.